Eocene Ltd. (EOCN) Key Metrics

NASDAQ: EOCNValuation, returns, debt and efficiency ratios over 4 years.

EOCN valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$3.0M
Enterprise value
−$7.2M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
—
Price / book
0.3
EV / EBITDA
0.3
Dividend yield
—
Beta
0.66

EOCN key metrics, 2022–2025

Fiscal year ended December 31, 2025 · U.S. dollars

EOCN returns How much profit the business earns on the capital it uses.

Return on equity−14.4 pts
−64.2%
2025 · hover or tap a bar for each year
2022: −133.1%2023: −50.6% (+82.5 pts)2024: −49.8% (+0.9 pts)2025: −64.2% (−14.4 pts)
20222025
Return on invested capital−13.6 pts
−57.3%
2025 · hover or tap a bar for each year
2022: −122.2%2023: −52.8% (+69.5 pts)2024: −43.7% (+9.1 pts)2025: −57.3% (−13.6 pts)
20222025
Return on assets−12.7 pts
−55.5%
2025 · hover or tap a bar for each year
2022: −107.9%2023: −41.7% (+66.2 pts)2024: −42.8% (−1.1 pts)2025: −55.5% (−12.7 pts)
20222025
Asset turnover
0.00
2025 · hover or tap a bar for each year
2022: 0.002023: 0.002024: 0.002025: 0.00
20222025

EOCN valuation history

Fiscal year-endToday4-year median

EOCN returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

EOCN debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

EOCN price vs earnings per share

Share price at year-endEPS (right axis)

EOCN key metrics

2022–2025
Eocene Ltd. key metrics by fiscal year
2025202420232022
Valuation
Market capitalization$4.9M———
Enterprise value$957,619———
Price / book0.3———
Earnings yield−208.6%———
Free cash flow yield−127.8%———
Share price at fiscal year-end$6.01$25.52$43.68$720.00
Per share
Revenue per share$0.00———
Earnings per share−$12.53———
Operating cash flow per share−$7.68———
Free cash flow per share−$7.68———
Cash per share$4.84———
Book value per share$19.18———
Tangible book value per share$19.18———
Capex per share$0.00———
Shares outstanding823K———
Returns & profitability
Return on equity (ROE)−64.2%−49.8%−50.6%−133.1%
Return on invested capital (ROIC)−57.3%−43.7%−52.8%−122.2%
Return on assets (ROA)−55.5%−42.8%−41.7%−107.9%
Return on tangible assets−55.3%−40.6%−41.6%−107.9%
Financial health
Cash & short-term investments$4.0M$4.7M$2.9M$2.0M
Net debt−$4.0M−$4.7M−$2.9M−$2.0M
Current ratio6.557.424.814.76
Quick ratio6.557.424.814.76
Working capital$15.8M$14.0M$10.5M$11.6M
Invested capital$11.8M$11.7M$11.0M$11.4M
Tangible asset value$15.8M$16.3M$13.9M$13.4M
Net current asset value$15.8M$14.0M$10.5M$11.6M
Graham net-net per share$1.39———
Capital allocation
Capex / depreciation—0.000.000.11
Efficiency
Asset turnover0.000.000.000.00
Average payables$1.7M$1.6M$2.2M$2.6M
Intangibles / total assets0.0%0.0%0.0%0.0%

Computed from EOCN's annual financial statements (latest annual report filed —) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

EOCN valuation and financial ratios

Eocene earned a return on equity of −64.2% and a return on invested capital of −57.3% in fiscal 2025.

See the EOCN income statement, the EOCN chart for price history, or the EOCN stock overview for the latest quote and news.

EOCN key metrics FAQ

What is Eocene's return on equity?

Eocene's return on equity (ROE) was −64.2% in fiscal 2025: net income of -$10.3 million on average shareholders' equity of $16.1 million.

What is Eocene's ROIC?

Eocene's return on invested capital was −57.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

What is Eocene's free cash flow yield?

Eocene generated -$6.3 million of free cash flow in fiscal 2025, a free cash flow yield of −127.8% on its market value at year-end ($4.9 million).

What is Eocene's current ratio?

Eocene's current ratio was 6.55 at the end of fiscal 2025: current assets were 6.55 times current liabilities.

Biotechnology key metrics